FdaApplication
NDA 212268
Identifiers
- fda_app_no: NDA212268
Properties
| Property | Value |
|---|---|
| applicant_name | HISAMITSU PHARMACEUTICAL CO INC |
| application_type | NDA |
| approval_date | 2019-10-11 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SECUADO | ASENAPINE | 3.8MG/24HR | SYSTEM;TRANSDERMAL |
| SECUADO | ASENAPINE | 7.6MG/24HR | SYSTEM;TRANSDERMAL |
| SECUADO | ASENAPINE | 5.7MG/24HR | SYSTEM;TRANSDERMAL |
3 products